#United States #New York #Class Action #Gross Law Firm #Baxter International

Legal Action Alert for Baxter International Shareholders

Introduction

Investors who faced financial losses involving Baxter International, Inc. (BAX) have a vital opportunity to engage with The Gross Law Firm, which is leading a class action lawsuit. If you acquired shares during the specified class period, your involvement could provide a chance for compensation. This article outlines the key details concerning the class action suit and what affected shareholders need to know.

Class Action Overview

On October 23, 2025, The Gross Law Firm officially notified shareholders of Baxter International about the ongoing class action suit against the company. This alert is particularly critical for individuals who purchased shares between February 23, 2022, and July 30, 2025. The lawsuit revolves around serious allegations that the company's product, Novum LVP, encountered significant malfunctions that allegedly jeopardized patient safety and led to injuries.

Allegations and Product Concerns

The allegations stipulate that Baxter International made false or misleading statements regarding the safety and efficacy of its recently launched product, Novum LVP. These accusations include:

• - Systematic defects in the Novum LVP resulted in serious malfunctions such as underinfusion, overinfusion, and even total failure in fluid delivery.
• - Baxter was aware of numerous complaints concerning device failures, which included incidents leading to significant injuries and fatalities.
• - The measures taken by Baxter, including issuing customer alerts, were deemed insufficient to rectify the ongoing design flaws, leading to continued harm.
• - Due to these issues, there was an increased likelihood that customers would have to remove existing Novum LVPs from service, and Baxter may need to halt all new sales of these pumps.

The nature of these allegations raises concerns not only about the integrity of the statements made by Baxter but also about the potential legal repercussions for the company.

Deadline for Shareholders

Shareholders must act quickly if they wish to participate in this class action. The deadline to register as a lead plaintiff in this case is set for December 15, 2025. It is essential that affected investors do not postpone their registration, as participation in the class action could be a critical avenue for recovery of losses sustained during this period.

Next Steps for Interested Shareholders

To take action, shareholders must register their information on The Gross Law Firm's website. Upon registration, they will be linked to a portfolio monitoring service that will provide updates throughout the litigation process. It's important to note that there is no cost or obligation to join this class action suit, and registration does not necessitate serving as a lead plaintiff.

Why Choose The Gross Law Firm?

The Gross Law Firm stands as a reputable national class action law firm dedicated to defending the rights of investors. Their mission focuses on protecting individuals who have suffered losses due to deceitful practices in the business landscape. Their commitment to corporate responsibility and fighting for shareholder rights reinforces the importance of pursuing this class action suit against Baxter International.

Contact Information

Investors interested in pursuing the class action should reach out to The Gross Law Firm directly. Here are some crucial contact details:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

In conclusion, shareholders of Baxter International, Inc. who have experienced financial setbacks due to the issues surrounding Novum LVP should act promptly to register for the class action suit. Taking this step may not only help recoup losses but also play a vital role in holding the company accountable for their actions concerning investor trust and product safety.